adenosine monophosphate has been researched along with Pulmonary Hypertension in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Ibe, JC; Raj, JU; Tang, H; Yuan, JX; Zhou, G; Zhou, Q | 1 |
| Bune, LT; Kylhammar, D; Rådegran, G | 1 |
| Barman, SA; Meadows, ML; White, RE; Zhu, S | 1 |
| Bradford, K; Deb, B; Pearl, RG | 1 |
4 other study(ies) available for adenosine monophosphate and Pulmonary Hypertension
| Article | Year |
|---|---|
Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Autophagy; Cell Survival; Cells, Cultured; Familial Primary Pulmonary Hypertension; Fibroblasts; Humans; Hypertension, Pulmonary; Hypoxia; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Pulmonary Artery; Pyrazoles; Pyrimidines | 2013 |
P2Y₁ and P2Y₁₂ receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Pressure; Deoxyadenine Nucleotides; Hypertension, Pulmonary; Hypoxia; Pulmonary Artery; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Swine; Vasoconstriction | 2014 |
Protein kinase C inhibits cyclic adenosine monophosphate-induced calcium-activated and voltage-activated potassium channel activity in fawn-hooded rat pulmonary arterial smooth muscle via phosphodiesterases.
Topics: Adenosine Monophosphate; Animals; Calcium; Disease Models, Animal; Hypertension, Pulmonary; Muscle, Smooth, Vascular; Phosphoric Diester Hydrolases; Potassium Channels; Protein Kinase C; Pulmonary Artery; Rats; Signal Transduction | 2005 |
Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
Topics: Adenosine Monophosphate; Administration, Inhalation; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Guanosine Monophosphate; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Male; Milrinone; Muscle, Smooth, Vascular; Nitric Oxide; Phosphodiesterase Inhibitors; Prospective Studies; Rabbits; Vascular Resistance; Vasodilator Agents | 2000 |